Pharmacokinetics describes the processes the body undergoes to metabolize and eliminate drugs, including absorption, distribution, metabolism, and excretion. Drugs can be administered topically, systemically, or directly to their target area. Orally administered drugs must dissolve and be absorbed through the stomach and intestines before entering systemic circulation. Some drugs are metabolized in the liver before circulating systemically, resulting in reduced bioavailability. Drugs can also be administered rectally but have disadvantages like slower absorption and potential irritation. A drug's absorption and distribution depend on its properties and formulation.
Factors affecting each of the proceses- Absorption, Distribution, Metabolism and Elimination of Drugs and associated Pharmacokinetic Parameters- Bioavailability, Volume of Distribution, Half life of drug, Rate of Clearance
ADME is a very important term used in pharmacology. "A" means absorption, "D" is for distribution, "M" is for metabolism and "E" is for excretion of drug in our body.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
Pharmacogenetics and pharmacogenomics is an upcoming branch in therapeutics. Various pharmacogenomic tests are currently available to aid in actual clinical practice. It has shown to have promising results in personalized medicine It is my attempt to compile the basic concepts from various books, articles, and online journals. Please feel free to comment.
Factors affecting each of the proceses- Absorption, Distribution, Metabolism and Elimination of Drugs and associated Pharmacokinetic Parameters- Bioavailability, Volume of Distribution, Half life of drug, Rate of Clearance
ADME is a very important term used in pharmacology. "A" means absorption, "D" is for distribution, "M" is for metabolism and "E" is for excretion of drug in our body.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
Pharmacogenetics and pharmacogenomics is an upcoming branch in therapeutics. Various pharmacogenomic tests are currently available to aid in actual clinical practice. It has shown to have promising results in personalized medicine It is my attempt to compile the basic concepts from various books, articles, and online journals. Please feel free to comment.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with pharmacokinetics : concept of linear and non-linear compartment models.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
Description on definition of pharmacogenetics, role of pharmacogenetics in drug response, role of polymorphism in drug metabolism, drug transporters and drug targets.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with pharmacokinetics : concept of linear and non-linear compartment models.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
Description on definition of pharmacogenetics, role of pharmacogenetics in drug response, role of polymorphism in drug metabolism, drug transporters and drug targets.
- Routes of administration
- First pass metabolism, bioavailablilty, drug distribution,
- Drug interactions with proteins, Drug metabolism, elimination, Half-life
Pharmacokinetics (PK) is the study of how the body interacts with administered substances for the entire duration of exposure (medications for the sake of this article). This is closely related to but distinctly different from pharmacodynamics, which examines the drug's effect on the body more closely.
ADME is the abbreviation for Absorption, Distribution, Metabolism and Excretion. ADME studies are designed to investigate how a chemical (e.g. a drug compound) is processed by a living organism. Toxicology tests are often a part of this process, yielding the acronym ADMET.
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptxMuhammad Kamal Hossain
Pharmacokinetics is defined as the kinetics of drug absorption, distribution, metabolism and excretion (ADME) and their relationship with the pharmacological, therapeutic or toxicological response in man and animals.
Abortion and other Causes of Early Pregnancy Bleeding.pdfChantal Settley
Describe common causes of bleeding in early pregnancy.
Describe the clinical classifications of abortion, the legal aspects of abortion in Ethiopia, and the safe methods used in health facilities.
Identify the warning signs and the emergency treatment required before referral for early pregnancy bleeding.
Describe the features of woman-friendly comprehensive post-abortion care, including the post-abortion family planning service
List the advantages of regionalised perinatal care.
Describe the functioning of a perinatal-care clinic.
Communicate better with patients and colleagues.
Safely transfer a patient to hospital.
Determine the maternal mortality rate.
Medical problems during pregnancy, labour and the puerperium.pdfChantal Settley
Diagnose and manage cystitis.
Reduce the incidence of acute pyelonephritis in pregnancy.
Diagnose and manage acute pyelonephritis in pregnancy.
Diagnose and manage anaemia during pregnancy.
Identify patients who may possibly have heart valve disease.
Manage a patient with heart valve disease during labour and the puerperium.
Manage a patient with diabetes mellitus.
Explain the wider meaning of family planning.
Give contraceptive counselling.
List the efficiency, contraindications and side effects of the various contraceptive methods.
List the important health benefits of contraception.
Advise a postpartum patient on the most appropriate method of contraception.
Define the puerperium.
List the physical changes which occur during the puerperium.
Manage the normal puerperium.
Assess a patient at the 6-week postnatal visit.
Diagnose and manage the various causes of puerperal pyrexia.
Recognise the puerperal psychiatric disorders.
Diagnose and manage secondary postpartum haemorrhage.
Teach the patient the concept of ‘the mother as a monitor’.
Uterine contractions continue, although less frequently than in the second stage.
The uterus contracts and becomes smaller and, as a result, the placenta separates.
The placenta is squeezed out of the upper uterine segment into the lower uterine segment and vagina. The placenta is then delivered.
The contraction of the uterine muscle compresses the uterine blood vessels and this prevents bleeding. Thereafter, clotting (coagulation) takes place in the uterine blood vessels due to the normal clotting mechanism.
Identify the onset of the second stage of labour.
Decide when the patient should start to bear down.
Communicate effectively with the patient during labour.
Use the maternal effort to the best advantage when the patient bears down.
Make careful observations during the second stage of labour.
Assess the fetal condition during the time the patient bears down.
Accurately evaluate progress in the second stage of labour.
Manage a patient with a prolonged second stage of labour.
Diagnose and manage impacted shoulders.
Monitoring the condition of the fetus during the first stage of labour.pdfChantal Settley
Monitor the condition of the fetus during labour.
Record the findings on the partogram.
Understand the significance of the findings.
Understand the causes and signs of fetal distress.
Interpret the significance of different fetal heart rate patterns and meconium-stained liquor.
Manage any abnormalities which are detected.
1.1 Define and use correctly all of the key terms
1.2 Describe the signs of true labour and distinguish between true and false labour
1.3 Explain to the mother how to recognise the onset of true labour
1.4 Describe the characteristic features and mechanisms of the four stages of labour
1.5 Describe the seven cardinal movements made by the baby as it descends the birth canal in a normal labour
10.2 Preterm labour and preterm rupture of the membranes.pdfChantal Settley
Define preterm labour and preterm rupture of the membranes.
Understand why these conditions are very important.
Understand the role of infection in causing preterm labour and preterm rupture of the membranes.
List which patients are at increased risk of these conditions.
Understand what preventive measures should be taken.
Diagnose preterm labour and preterm rupture of the membranes.
Manage these conditions.
Understand why an antepartum haemorrhage should always be regarded as serious.
Provide the initial management of a patient presenting with an antepartum haemorrhage.
Understand that it is sometimes necessary to deliver the fetus as soon as possible, in order to save the life of the mother or infant.
Diagnose the cause of the bleeding from the history and examination of the patient.
Correctly manage each of the causes of antepartum haemorrhage.
Diagnose the cause of a blood-stained vaginal discharge and administer appropriate treatment.
Define hypertension in pregnancy.
Give a simple classification of the hypertensive disorders of pregnancy.
Diagnose pre-eclampsia and chronic hypertension.
Explain why the hypertensive disorders of pregnancy must always be regarded as serious.
List which patients are at risk of developing pre-eclampsia.
List the complications of pre-eclampsia.
Differentiate pre-eclampsia from pre-eclampsia with severe features.
Give a practical guide to the management of pre-eclampsia.
Provide emergency management for eclampsia.
Manage gestational hypertension and chronic hypertension during pregnancy.
7.2 New Microsoft PowerPoint Presentation (2).pdfChantal Settley
Welcome the woman and ask her to sit near you and facing you.
Smile and make good eye contact with her.
Reassure her that you will always maintain her privacy and confidentiality
Without her permission, do not include a third person in the meeting.
Use simple non-medical language and terminologies throughout that she can understand, and check frequently that she has really understood.
Actively listen to her, using gestures and verbal communication to show her that you are paying attention to what she says.
Encourage her to ask questions, express her needs and concerns, and seek clarification of any information that she does not understand.
6.4 Assessment of fetal growth and condition during pregnancy.pdfChantal Settley
When you have completed this unit you should be able to:
• Assess normal fetal growth.
• List the causes of intra-uterine growth restriction.
• Understand the importance of measuring the symphysis-fundus height.
• Understand the clinical significance of fetal movements.
• Use a fetal-movement chart.
• Manage a patient with decreased fetal movements.
• Understand the value of antenatal fetal heart rate monitoring.
What possible complications to look for:
Antepartum haemorrhage
Pre-eclampsia
proteinuria and a rise in the blood pressure.
Cervical changes
Symphysis-fundus height measurement
below the 10th centile?
above the 90th centile?
To review and act on the results of the screening or special investigations done at the booking visit.
2. To perform the second assessment for risk factors.
If possible, all the results of the screening tests should be obtained at the first visit.
Assess normal fetal growth.
List the causes of intra-uterine growth restriction.
Understand the importance of measuring the symphysis-fundus height.
Understand the clinical significance of fetal movements.
Use a fetal-movement chart.
Manage a patient with decreased fetal movements.
Understand the value of antenatal fetal heart rate monitoring.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
2. Pharmacokinetics of drugs p29 (definition)
• It is the effect of the body on the drug molecules
over time through the following processes:
• Absorption
• Distribution
• Metabolism (bio-transformation)
• Elimination /excretion
Compiled by C Settley
3. Pharmacokinetics
• Topical delivery- application to body areas where they
exert localised effects. Eg a cream/lotion. These drugs do
not require absorption into the systemic blood
circulation to be effective.
• Systemic drugs- need to be administered in such a way
as to allow them to be absorbed into the systemic blood
circulation.
• Some drugs are administered directly into their target
areas.
Compiled by C Settley
5. Oral route
• Dissolves- enters the bloodstream- hepatic portal
circulation- systemic circulation.
Compiled by C Settley
6. The oral route
• All oral medication are dissolved in the lumen of the
GIT. Most dissolve in the stomach, unless formulated
to disintegrate and dissolve further down in the
alimentary canal.
• The stomach cannot be regarded as an absorption
organ but may allow some of the dissolved drug
molecules to enter into the bloodstream. The small
intestine is the primary site of the absorption of
drugs.
Compiled by C Settley
7. The oral route
• From the stomach and small intestines, drug molecules have
to cross biological membranes to reach the hepatic portal
circulation.
• Blood entering the portal circulation then moves through the
portal vein, liver, inferior vena cava, right side of the heart,
pulmonary circulation and the left side of the heart before
finally entering the systemic circulation, from where absorbed
drug molecules will be distributed to other parts of the body.
• Per oz, per os, PO, peroral, per mouth
Compiled by C Settley
9. First pass metabolism- pg31
• The first-pass effect (also known as first-pass metabolism or pre
systemic metabolism/elimination) is a phenomenon of drug
metabolism whereby the concentration of a drug is greatly reduced
before it reaches the systemic circulation. It is the fraction of drug
lost during the process of absorption which is generally related to
the liver and gut wall.
• After a drug is swallowed, it is absorbed by the digestive system and
enters the hepatic portal system. It is carried through the portal
vein into the liver before it reaches the rest of the body. The liver
metabolizes many drugs, sometimes to such an extent that only a
small amount of active drug emerges from the liver to the rest of
the circulatory system. This first pass through the liver thus greatly
reduces the bioavailability of the drug.
Compiled by C Settley
11. Rectal route (per rectum, PR)
• Unpopular & uncomfortable
• Indications for this route?
• Absorptive surface of the rectum is small.
• Results in slowed rate of rectal absorption.
• The rectum is drained by three veins: superior,
middle and the inferior rectal veins .
• The inferior and middle rectal veins drain the
lower part of the rectum, while the superior rectal
vein drains the upper part.
Compiled by C Settley
12. Rectal route (per rectum, PR)
• Drugs administered into the proximal rectum are
subjected to first-pass metabolism. However, drugs
administered from a low rectal site reach the general
circulation without first passing through the liver.
• Additionally, some drugs can cause irritation of the
rectal mucosa. Informed consent must be sought
prior to administration of any rectal preparation
especially if given during general anaesthesia.
Compiled by C Settley
13. The disadvantages associated with
administration of drugs rectally include:
• (a) interruption of absorption by defecation, which may
occur particularly with irritant drugs;
• (b) the surface area of the rectum is far smaller for
absorption than that of the duodenum;
• (c) the fluid contents of the rectum are much smaller than
those of the duodenum and this may produce problems
with dissolution of some drugs;
• (d) degradation of some drugs by micro-organisms may
occur in the rectum;
• (e) patient acceptability may be a problem
Compiled by C Settley
14. Systemic bioavailability (pg 42)
• This is the percentage of the oral drug that actually
reaches the systemic blood circulation
• Only a fraction of an oral drugs dosage actually reaches
the systemic blood circulation
• Reasons for this include:
– Not all drug molecules are absorbed from the GIT
– First pass effect
• The liver may eliminate a significant portion of the drug.
Compiled by C Settley
15. Absorption (pg36)
• Absorption is the movement of a drug into the bloodstream.
• Drug absorption is determined by the drug’s physicochemical
properties, formulation, and route of administration.
• Dosage forms (eg, tablets, capsules, solutions), consisting of
the drug plus other ingredients, are formulated to be given by
various routes (eg, oral, buccal, sublingual, rectal, parenteral,
topical, inhalational).
• Regardless of the route of administration, drugs must be in
solution to be absorbed.
• The easier it crosses plasma membranes the more readily it
will be absorbed.
• The intravenous route bypasses this stage.
Compiled by C Settley
17. Absorption: The plasma membrane
• The barrier between:
• Intracellular and
• Extracellular fluid
• The barrier may be crossed by:
• Diffusion (the spreading of something more widely)
• Active transport (the movement of ions or molecules across a cell
membrane into a region of higher concentration, assisted by enzymes and
requiring energy)
Compiled by C Settley
18. Absorption: properties of the drug molecule
Certain properties of the drug molecules will determine their
ability to cross the membrane
• Lipid solubility
– More lipid soluble drugs cross cell membranes more easily
• Size of the drug molecules
– Smaller molecules cross more easily
• Ionisation of the drug molecules
– Unionised molecules cross cell membranes more easily (Ionization is
the process by which an atom or a molecule acquires a negative or
positive charge by gaining or losing electrons to form ions, often in
conjunction with other chemical change)
Compiled by C Settley
19. Distribution (pg 42)
• The systemic blood circulation transports the drug molecules to
other parts of the body.
• The molecules then leave the blood stream (capillaries) at their
sites of action to enter other fluid compartments of the body.
• Organs that receive the greatest percentage of cardiac output
receive the greatest percentage of the absorbed drug.
• In other words after a drug enters the systemic circulation, it is
distributed to the body's tissues. Distribution is generally uneven
because of differences in blood perfusion, tissue binding (eg,
because of lipid content), regional pH, and permeability of cell
membranes
Compiled by C Settley
20. Drug elimination- pg 43
• Drug action may be terminated by:
• Biotransformation (Biotransformation is the process whereby a substance is
changed from one chemical to another (transformed) by a chemical reaction
within the body. Metabolism or metabolic transformations are terms frequently
used for the biotransformation process)
• Excretion (Excretion is the process by which waste products of metabolism and
other non-useful materials are eliminated from an organism)
• Redistribution (reversible transfer of drug from one location to another within the
body)
• Tolerance (Tolerance is a person's diminished response to a drug, which occurs
when the drug is used repeatedly and the body adapts to the continued presence
of the drug. Resistance refers to the ability of microorganisms or cancer cells to
withstand the effects of a drug usually effective against them)
Compiled by C Settley
21. Metabolism- pg 44
• The liver is the primary responsible organ for
biotransformation
• Other tissues participate in metabolism:
• Lungs
• Kidneys
• Skin
• Adrenal cortex
• Brain
• Gastrointestinal tract
Compiled by C Settley
22. Excretion (pg47)
• Drugs may be excreted via:
• The lungs
• Gastrointestinal tract & liver
• Kidneys
• Saliva, tears, perspiration
• A drug’s concentration is highest in the organ that
excretes it.
Compiled by C Settley
23. Applied pharmacokinetics (pg 48)
• Elimination half life (t½)
• The amount of time for the drug’s plasma
concentration to be reduced by 50%
• Half life of a drug may be prolonged by kidney / liver
failure / aging.
• Used to determine dosage interval
Compiled by C Settley
24. Applied pharmacokinetics
• Loading dosages
• A loading dosage /bolus is given to obtain the
required therapeutic effect more rapidly
Compiled by C Settley
25. Applied pharmacokinetics
• Maintenance dosages
• Are given at regular intervals
• To reach and maintain the desired constant
therapeutic levels (steady state concentration)
Compiled by C Settley
26. Applied pharmacokinetics
• Therapeutic index
• The difference between the minimum plasma concentrations
of the drug
• At which it is effective
• And at which it is toxic
• The therapeutic index indicates a drug’s margin of safety
• Drugs with a narrow therapeutic index reach toxic levels very
easily
• E.g: warfarin, theophylline, phenytoin
Compiled by C Settley
27. Medicine administration
• The 5 R’s of medication administration
– Right patient
– Right medication
– Right dose
– Right time
– Right route
NB. Medication administration done under the
supervision of a R/N (R2598)
Compiled by C Settley